DANA TOLMAN: Open Payments
NPI 1396242376 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 21 payments from 11 companies in 2025. Trend: 2023 $4,246 · 2024 $9,013 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $104 |
| PFIZER INC. | 4 | $81 |
| Genentech USA, Inc. | 2 | $50 |
| Stemline Therapeutics Inc. | 2 | $44 |
| TerSera Therapeutics LLC | 1 | $38 |
| Lilly USA, LLC | 2 | $37 |
| Myriad Genetic Laboratories, Inc. | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $20 |
Products named: KEYTRUDA, IBRANCE, Itovebi, Orserdu, Zoladex, VERZENIO, MYRISK, TALVEY.
Industry payments across FL — which companies pay providers there.
